The global pharmaceutical industry experienced a 2% drop in new job postings related to environmental sustainability in Q3 2022 compared with the previous quarter, according to GlobalData’s whitepaper on Environmental Sustainability in Pharmaceutical – Hiring Activity in Q3 2022. This compares to a 22% increase versus Q3 2021.
Notably, Building Cleaning Workers jobs accounted for a 9% share of the global pharmaceutical industry’s environmental sustainability-related total new job postings in Q3 2022, up 1% over the prior quarter.
Building Cleaning Workers, with a share of 9%, emerged as the top environmental sustainability-related job roles within the pharmaceutical industry in Q3 2022, with new job postings rising by 1% quarter-on-quarter. Registered Nurses came in second with a share of 9% in Q3 2022, with new job postings drop by 22% over the previous quarter.
The other prominent environmental sustainability roles include Environmental Science and Geoscience Technicians with a 4% share in Q3 2022, Nursing Assistants, Orderlies, and Psychiatric Aides with a 3% share of new job postings.
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q3 2022 were Houston Methodist Hospital, Johnson & Johnson, Alberta Health Services and Eurofins Scientific. Together they accounted for a combined share of 3% of all environmental sustainability-related active jobs in the pharmaceutical industry.
Houston Methodist Hospital posted 3,481 jobs in Q3 2022 and registered a drop of 6% over the previous quarter, followed by Johnson & Johnson with 637 jobs and a 38% growth. Alberta Health Services with 606 jobs and Eurofins Scientific with 530 jobs, recorded a 16% decline and a 26% increase, respectively, while Trinity Health recorded a 17% decline with 464 job postings during Q3 2022.
The largest share of environmental sustainability-related new job postings in the pharmaceutical industry in Q3 2022 was in the US with 86% followed by Canada (3%) and Australia (2%). The share represented by the US was 0.28 percentage points lower than the 86% share it accounted for in Q2 2022.